文献速递眼底病与葡萄膜炎

家庭光学相干断层扫描引导下管理既往接受过治疗的新生血管性年龄相关性黄斑变性患者的前瞻性试验

PROSPECTIVE TRIAL OF HOME OPTICAL COHERENCE TOMOGRAPHY-GUIDED MANAGEMENT OF TREATMENT EXPERIENCED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION PATIENTS.
PubMed 文献 · Retina · 2024-09-12

一项干预性试验比较新生血管性年龄相关性黄斑变性患者使用家庭OCT前6个月与使用期间6个月的治疗频率和视力,共15例患者27只眼,扫描频率为每眼每周6.2次,期间每次注射间隔周数从8.0周延长至15.3周(P=0.004),视力变化无显著差异(P=0.45)。

要点

  • 家庭OCT管理期间每次注射间隔周数较管理前显著延长(8.0周 vs 15.3周,P=0.004)。
  • 家庭OCT管理前后视力变化无显著差异(3.5个字母 vs 0.0个字母,P=0.45)。
  • 共获得4435次扫描,其中91.2%符合基于人工智能的液体体积量化条件。

核心结论

  • 远程患者监测结合家庭OCT首次实现了新生血管性年龄相关性黄斑变性的个性化管理。
  • 本研究显示治疗负担显著降低,同时视力保持稳定。

研究设计与样本

  • 一项干预性试验,比较新生血管性年龄相关性黄斑变性患者使用家庭OCT前与使用期间6个月的治疗频率和视力。
  • 共纳入15例患者27只眼(其中21只眼诊断为新生血管性年龄相关性黄斑变性,1只眼在研究期间转换),监测6个月。
  • 通过每周扫描次数衡量患者对规律扫描的依从性,并分析液体复发事件特征及典型液体体积轨迹分类。

主要发现

  • 扫描频率为每眼每周6.2次,共获得4435次扫描,其中91.2%符合基于人工智能的液体体积量化条件。
  • 研究前和研究期间的监测总周数分别为1555周和509周。
  • 家庭OCT管理前和管理期间每次注射的平均(SD)周数分别为8.0(4.7)周和15.3(8.5)周(P=0.004)。
  • 家庭OCT管理前和管理期间视力变化的平均(SD)分别为3.5(12.0)个字母和0.0(9.5)个字母(P=0.45),显示对视力无显著影响。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the impact of home optical coherence tomography (OCT)-guided patient management on treatment burden and visual outcomes. METHODS: An interventional trial was conducted to compare frequency of treatment and visual acuity for the neovascular age-related macular degeneration patients before and during use of home optical coherence tomography over a period of 6 months. Patient adherence to regular scanning was measured by the number of scans performed per week. The characteristics of episodes of fluid recurrence and classification of typical fluid volume trajectories were performed. RESULTS: Twenty-seven eyes (21 with diagnosis of neovascular age-related macular degeneration and one converted during the study), of 15 patients were monitored for 6 months, scanning at 6.2 times/week per eye and yielding 4,435 scans of which 91.2% were eligible for artificial intelligence-based fluid volume quantification. Total number of monitoring weeks before and during the study were 1,555 and 509. The mean (SD) number of weeks per injection before and during home OCT management were 8.0 (4.7) and 15.3 (8.5) (P = 0.004), respectively. The mean (SD) visual acuity change before and during home OCT-based management was 3.5 (12.0) letters and 0.0 (9.5) letters (P = 0.45), respectively, showing no significant impact on visual acuity. CONCLUSION: For the first time, remote patient monitoring with a home OCT allowed personalized management of neovascular age-related macular degeneration. This study showed significant reduction in treatment burden while maintaining stable visual acuity.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Holekamp NM, de Beus AM, Clark WL, et al. PROSPECTIVE TRIAL OF HOME OPTICAL COHERENCE TOMOGRAPHY-GUIDED MANAGEMENT OF TREATMENT EXPERIENCED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION PATIENTS. Retina. 2024. PMID: 39287534. doi:10.1097/IAE.0000000000004167

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。